Earnings Call · Q1 FY2022·2022-05-05

Q1 22EPS +13.96%·Rev n/aQ4 21EPS +100.00%*·Rev n/aQ3 21EPS -0.78%·Rev n/aQ2 21EPS +2.92%·Rev n/a⚠ consensus missing

Karyopharm Therapeutics Inc. KPTI

Elhan Webb — Senior Vice President, Investor Relations

Richard Paulson — President and CEO

Sohanya Cheng — Chief Commercial Officer

Reshma Rangwala — Chief Medical Officer

Patricia Judson

Michael Mason — Chief Financial Officer

+1.2%1d on move date+4.8% vs SPY3d−24.2%5d−21.8%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KPTI calls or request research access.

More KPTI calls Browse calls Request research access